Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayJun 24, 2025 3:28 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights GBM Treatment Insights in KOL Segment Featuring Dr. Erin Dunbar 

CNS Pharmaceuticals (NASDAQ: CNSP) announced the release of a Virtual Investor KOL Connect segment featuring Dr. Erin Dunbar, Director of Neuro-Oncology at Piedmont Atlanta Hospital and founding physician of its Brain Tumor Center. Dr. Dunbar discussed the patient journey and current treatment options for Glioblastoma Multiforme (GBM), highlighting CNS’s lead product candidate, TPI 287, and its therapeutic potential for GBM and future metastatic tumor indications. To view the full press release, visit https://nnw.fm/MBIkc About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of…

Continue Reading

TuesdayJun 24, 2025 2:45 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model 

InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company developing small molecule drug candidates for diseases with high unmet medical needs, announced new preclinical data showing that INM-901 significantly reduces inflammation in ex vivo models of neuroinflammation. The compound demonstrated a dose-dependent and statistically significant reduction in pro-inflammatory cytokines IL-6, IL-1β, IL-2, KC/Gro, and inflammasome marker NLRP3—key factors in Alzheimer’s disease progression. Notably, the effects were independent of amyloid beta or tau pathology, highlighting INM-901’s broader potential in treating neurodegenerative diseases. The orally administered compound also targets CB1/CB2 receptors and PPARs and has shown improvements in cognition and behavior in long-term animal…

Continue Reading

TuesdayJun 24, 2025 12:57 pm

NetworkNewsBreaks – Fusion Fuel Green PLC (NASDAQ: HTOO) Subsidiary Secures $1.2 Million in New UAE Energy Projects 

Fusion Fuel Green (NASDAQ: HTOO) i.e., Fusion Fuel, announced its majority-owned subsidiary, Al Shola Al Modea Gas Distribution LLC (“Al Shola Gas”), secured AED 4.4 million (~$1.2 million USD) in new engineering and utility projects across Dubai. The new awards include developments in Dubai Marina, Business Bay, Satwa, and other districts, adding to the more than $2.7 million in contracts previously disclosed in May. All projects will generate recurring revenue through long-term utility agreements. Al Shola Gas’s customer base now exceeds 12,000, with bulk LPG volumes over 600 metric tons monthly and a year-end target of 800 metric tons. Executives…

Continue Reading

TuesdayJun 24, 2025 10:45 am

NetworkNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) to Launch Pawpa(TM) Regen Nationwide as Stem Cell-Based Canine Supplement Gains Momentum

BioAdaptives (OTC Pink: BDPT), a leader in nutraceutical and wellness innovation, will launch its proprietary canine supplement Pawpa(TM) Regen nationwide by the end of July 2025. Designed to support natural stem cell activation in aging dogs, the supplement has shown promising results in early trials, including improved energy, mobility, coat quality, and temperament. CEO James Keener emphasized the product’s unique regenerative approach using safe, naturally sourced ingredients. With strong early feedback and growing demand for holistic pet care solutions, BioAdaptives is expanding production ahead of the broader e-commerce rollout. To view the full press release, visit https://nnw.fm/4ys2R About BioAdaptives, Inc.…

Continue Reading

TuesdayJun 24, 2025 10:25 am

NetworkNewsBreaks – Roth Capital Partners, LLC Leads DoubleDown Interactive (NASDAQ: DDI) $8.50 Secondary Offering of 4.35M ADSs

Roth Capital Partners is serving as lead bookrunning manager for DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) in a priced secondary offering of 4,347,827 American Depositary Shares (ADSs) at $8.50 each. The ADSs, representing 0.05 common share per unit, are being sold by STIC Special Situation Diamond Limited, which has also granted underwriters a 30-day option to purchase up to 652,173 additional ADSs. The company will not receive proceeds from the sale, and the offering will not alter the number of shares outstanding. Texas Capital Securities is acting as co-bookrunning manager, with closing expected on or about June 13, 2025, subject…

Continue Reading

TuesdayJun 24, 2025 9:38 am

NetworkNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Gains Spotlight in NetworkNewsWire Editorial Amid Gold Surge 

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) has been featured in a new editorial by NetworkNewsWire highlighting the company’s strategic position in Canada’s leading gold district. With gold prices surpassing US$3,300 per ounce in early 2025 and projections pushing toward US$4,000, LaFleur’s fully permitted gold mill offers near-term production potential and strong leverage to bullion’s upside. As investors seek reliable exposure in stable jurisdictions, LaFleur aims to emerge as a key player among Canada’s established gold producers. To view the full press release, visit https://nnw.fm/Icx7d About LaFleur Minerals Inc. LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) is…

Continue Reading

TuesdayJun 24, 2025 9:10 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch

NRx Pharmaceuticals (NASDAQ: NRXP) a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, has engaged IBN to manage its corporate communications strategy. NRx is advancing two FDA-designated therapies—NRX-100 and NRX-101—with an NDA underway for NRX-100 and additional regulatory filings in progress. The company also launched HOPE Therapeutics, a subsidiary focused on building a national psychiatric care network, with plans for a public spin-out. IBN will leverage its extensive media portfolio to expand investor awareness and outreach. To view the full press release, visit https://nnw.fm/Gj54q About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics…

Continue Reading

TuesdayJun 24, 2025 9:00 am

NetworkNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Announces 1-for-10 Reverse Share Split to Regain Nasdaq Compliance

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company pursuing a multi-club ownership (“MCO”) strategy in global sports, will implement a 1-for-10 reverse share split of its Class A and Class B ordinary shares effective June 26, 2025, to meet Nasdaq’s minimum bid price requirement. Following shareholder and board approval, the split will reduce the number of Class A shares from approximately 6.3 million to 633,800 and Class B shares from 17.8 million to 1.78 million, while increasing nominal share value from $0.005 to $0.05. Fractional shares will be rounded up, and no shareholder action is required. To view the…

Continue Reading

MondayJun 23, 2025 1:29 pm

NetworkNewsBreaks – US~Observer Investigates Morpheus Research After Reports Trigger Sharp Stock Declines 

US~Observer, a national investigative news outlet known for exposing corruption and defending the wrongly accused, has launched a probe into Morpheus Research, a recently formed short-report entity endorsed by Hindenburg Research founder Nate Anderson. The investigation follows a string of Morpheus reports targeting Solaris Energy Infrastructure (NYSE: SEI), Backblaze (NASDAQ: BLZE), Abacus Global Management (NASDAQ: ABL), and Mercurity Fintech Holding (NASDAQ: MFH)—each followed by steep stock drops ranging from 5% to more than 30%.  Morpheus Research, which claims to expose corporate fraud, has drawn criticism for its lack of transparency, undisclosed funding sources, and close ties to Hindenburg alumni. Although…

Continue Reading

MondayJun 23, 2025 11:40 am

NetworkNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Acquires Nautical Ventures to Launch First Integrated Electric Boat Dealership in North America

Vision Marine Technologies (NASDAQ: VMAR), a leader in high-voltage electric marine propulsion, has acquired Nautical Ventures Group, a top U.S. boat dealership and 2024 Boating Industry “Dealer of the Year.” The move establishes North America’s first combined electric boat propulsion and dealership platform, pairing Vision Marine’s E-Motion(TM) powertrain with Nautical Ventures’ extensive retail network, inventory, and service capabilities. With nine Florida locations and a portfolio that includes brands like Axopar, Yamaha, and Beneteau, Nautical Ventures provides Vision Marine direct access to one of the world’s most active boating markets. The acquisition adds direct-to-consumer capabilities, expanded revenue streams, and positions the…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000